Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Woth a second look, anyone new, should see

<< Previous

Bullboard Posts

Next >>

Post by canadafanon Jan 19, 2022 1:48pm

367 Views

Post# 34333763

Woth a second look, anyone new, should see

This was a recent investor update.
Anyone new to the game shuld read.
This seemed tp have kicked off the recent run

https://www.oncolyticsbiotech.com/press-releases/detail/555/oncolytics-biotech-releases-a-letter-to-shareholders-

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?